Optimal CGM Targets at 29 Weeks Lower Risk of Adverse Outcomes in Gestational Diabetes
21 Aug 2025 • A secondary analysis of women with gestational diabetes mellitus (GDM) and BMI ≥25 kg/m² found that continuous glucose monitoring (CGM) targets at 29 weeks’ gestation strongly predicted pregnancy outcomes.
Key Findings:
- Women achieving mean glucose <110 mg/dL, time in range (TIRp) ≥90%, or time above range (TARp) <10% (within 63–140 mg/dL) had markedly lower odds of both large- and small-for-gestational-age infants (ORs ~0.3–0.4).
- Moreover, TARp <10% and mean nocturnal glucose <110 mg/dL were associated with reduced preterm birth risk.
These findings highlight CGM-based thresholds that can optimize neonatal outcomes in GDM pregnancies.
Source: BMJ Journals | Read Full Story